ECM
GMAB icon

ETrade Capital Management’s Genmab GMAB Stock Holding History

ETrade Capital Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$2.04M Sell
55,634
-12,985
-19% -$469K 0.04% 218
2020
Q2 		$2.33M Buy
68,619
+10,825
+19% +$295K 0.05% 209
2020
Q1 		$1.23M Buy
+57,794
New +$1.29M 0.03% 255

Other funds holding GMAB

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

ETrade Capital Management's GMAB Position: Q3 2020 in Review

ETrade Capital Management reduced its Genmab (GMAB) stake by 19% in Q3 2020, selling an estimated $469K and leaving 55,634 shares worth $2.04M. The position accounts for 0.04% of the portfolio, ranked #218.

ETrade Capital Management first reported a position in GMAB in Q1 2020 and has held it in 3 quarters since. The position peaked at $2.33M in Q2 2020. 199 funds tracked by Wall St. Rank hold GMAB as of Q3 2020.

  • ETrade Capital Management held 55,634 shares of Genmab worth $2.04M as of Q3 2020.
  • ETrade Capital Management sold 12,985 Genmab shares in Q3 2020, an estimated $469K.
  • Genmab made up 0.04% of ETrade Capital Management's portfolio in Q3 2020, its #218 holding.
  • ETrade Capital Management first reported a position in Genmab in Q1 2020 and has held it in 3 quarters since.
  • ETrade Capital Management's Genmab position peaked at $2.33M in Q2 2020.
  • 199 funds tracked by Wall St. Rank held Genmab as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.